Komori
General Meetings of Shareholders9267Genky DrugStores Co.,Ltd.Retail

Notice of Convocation of the 2026 Annual General Meeting of Shareholders and Meeting Materials

The 9th Annual General Meeting of Shareholders will be held on 10 September 2026, with 3 proposals to be submitted for resolution: a year-end dividend, the election of 5 directors, and the issuance of stock options. All director nominees are incumbent directors, and the election of outside directors is not included in the proposals for this meeting.

Worth reading
39Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Resolutions for the General Meeting of Shareholders

Annual (9th fiscal year)
2026
Sep 10
Date and time(Thursday), 10:00 a.m.23 days from this disclosure to the meeting
Matters for resolution3 items
  1. Appropriation of surplus

  2. Election of 5 directors (excluding directors who are Audit and Supervisory Committee members)

  3. Issuance of share acquisition rights as stock options

Shareholder Proposal

No

A shareholder proposal is a resolution submitted by a shareholder, rather than by the company.
Director nominee
5Nominees
0New
0Outside
Resolutions for the General Meeting of Shareholders
ItemDetails
Type of shareholders' meetingAnnual (9th fiscal year)
Date and time10 September 2026 (Thursday), 10:00 a.m.
Matters for resolutionProposal 1: Appropriation of surplus, Proposal No. 2: Election of 5 directors (excluding directors who are Audit and Supervisory Committee members), Proposal No. 3: Issuance of share acquisition rights as stock options
Shareholder ProposalNo
Director nominee5, including 0 new candidates and 0 outside directors
Items this document does not state (1)
Percentage voting in favor

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The year-end dividend reflects the company's performance for the fiscal year and its future business development. The stock options are intended to increase motivation and morale toward improving consolidated performance and contribute to the expansion of the business.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Convocation of the 2026 Annual General Meeting of Shareholders and Meeting Materials | Genky DrugStores Co.,Ltd. (9267) timely disclosure | Komori